Similarly, when YTHDF2 forms a complex with CBSLR/YTHDF2/CBS, it destabilizes CBS mRNA in an m6A-dependent manner, leading to ACSL4 degradation via the ubiquitin-proteasome pathway and inhibiting ferroptosis in the hypoxic tumor microenvironment [64]. The gene discussed is CBS; the disease is neoplasm.